Monday, August 18, 2014
Why I'm skeptical about marijuana's medical benefits
There’s a little place up the street from me with a great beer list. My favorite is a Trappist ale that I order maybe once or twice a year (an ale whose name I never remember but simply refer to as “my medicine”). It’s great after a particularly stressful day, not because of the serenity of the monks who brew it, but because of its ridiculously high alcohol content. A glass of this medicine takes the edge off of just about anything.
As of July 5, the state of New York has a medical marijuana program. Medical cannabis laws have become the “gateway” law toward full legalization. Legalized medicinal use of marijuana has become less and less controversial, the main exceptions being anti-drug zealots and doctors and scientists who look at the evidence objectively.
Decriminalization and medical use of pot are (or should be) separate questions. The decision to legalize pot should be based on a risk-benefit analysis: are we better off tossing people in jail for using a relatively mild drug, and supporting an illegal trade, or should we make it legal, regulate it, and tax it?
The medical use of marijuana is a different question, not one of social policy but of science: are there specific medical benefits to cannabis? If so, what are they? Should we look at pot as another legal drug like alcohol and tobacco, or should we treat it as medicine?
If we are going to treat pot as medicine, it will have to do a better job at proving itself worthy of that title. There are plenty of prescription medicines of questionable benefit and with the potential to harm. Some are worse than useless, despite being legal, and some are nearly miraculous. Where does cannabis fit in?
The science so far doesn’t look good. At this point, despite thousands of studies, there is very little evidence that cannabis is good for any specific medical condition. If you choose to cherry-pick the data a bit, you can find some evidence for benefit in some sorts of painful nerve disorders. And that’s about it. Pot, when tested alone or compared to currently available treatments doesn’t seem to carry any of the advantages touted by its supporters.
This isn’t to say marijuana has no benefits. Many people report it helps them with the symptoms of a wide variety of medical conditions. But is this any different from my Trappist medicine?
Maybe. As research continues into the various chemicals that marijuana carries into your body, our understanding (which is already impressive) will grow. We probably will find some use for marijuana, but I doubt it will be a stand-out in our pharmacopoeia. Like any scientist, my mind is open to new data, to altering my hypothesis as the evidence changes. But one thing we’ve learned in medicine in the last century is that it can be dangerous to leap too far out ahead of the evidence. The line between excitement about a potential new medication and hucksterism is a narrow one.
The Wall Street Journal (disclosure: not my favorite editorial page) just published an opinion piece in support of medical marijuana, one that should be viewed with skepticism. The author, Steven Patierno, explains how non-smoked cannabis, in carefully documented doses, can bring great benefit. His industry disclosure shows him to chair the medical board of a company called PalliaTech that—surprise, surprise—works on developing carefully dosed, non-smoked cannabis medications. This doesn’t invalidate everything he writes, but it makes it suspect, especially if he doesn’t give us hard data (he doesn’t).
Last night I watched a CNN piece on medical marijuana (“Weed2″). It followed the sad case of a young girl with a horrible seizure disorder and her parents’ struggle to get her help. According to Sanjay Gupta, they finally found some help with cannabis, and the piece documents their struggle to get their daughter the medicine that they believe is helping her.
It makes for a great story, but it gives us no help in deciding if marijuana has any legitimate medical uses. A thorough search of the medical literature finds no good studies that support the use of cannabis or any of its constituents in seizure disorders. This doesn’t invalidate this family’s experiences: perhaps this is worthy of further study. What alarms me is the implication that a good parent is the one who gets an unproven medication for their child, no matter the evidence.
If I were the parent of a child with a rare disease, I would probably do as the family on CNN. I’d try anything. But as a doctor, I’d recommend against using what is clearly a powerful drug/medication in a way that may do no good and may even cause harm, especially in a child.
The active chemicals in marijuana have many effects on the brain, and likely elsewhere in the body. These effects are worthy of continued study, and I wouldn’t be surprised if marijuana or drugs derived from it find a legitimate place in the pharmacy. At this point, though, it’s mostly hope, fantasy, and guesswork.
The question of legalization is an important one, but distinct from pot’s potential as medicine. One is a decision based on our values. The other on cold, hard, dispassionate science. We should keep this distinction clear and stop using medical marijuana as a stepping stone to legalization.
Peter A. Lipson, ACP Member, is a practicing internist and teaching physician in Southeast Michigan. After graduating from Rush Medical College in Chicago, he completed his internal medicine residency at Northwestern Memorial Hospital. This post first appeared at his blog at Forbes. His blog, which has been around in various forms since 2007, offers "musings on the intersection of science, medicine, and culture." His writing focuses on the difference between science-based medicine and "everything else," but also speaks to the day-to-day practice of medicine, fatherhood, and whatever else migrates from his head to his keyboard.
Contact ACP Internist
Send comments to ACP Internist staff at firstname.lastname@example.org.
- More on physician autonomy
- The basic health care transaction
- Largest Ebola outbreak in history continues to spr...
- One physician's take on ACP's CME offering about h...
- Medical fright: Ebola
- The urgencies of care: here, there, and everywhere...
- A clinical prediction rule for kidney stones
- Tanzania, part 2
- What the HAC?!
- Independence and autonomy
Members of the American College of Physicians contribute posts from their own sites to ACP Internistand ACP Hospitalist. Contributors include:
Albert Fuchs, MD, FACP, graduated from the University of California, Los Angeles School of Medicine, where he also did his internal medicine training. Certified by the American Board of Internal Medicine, Dr. Fuchs spent three years as a full-time faculty member at UCLA School of Medicine before opening his private practice in Beverly Hills in 2000.
And Thus, It Begins
Amanda Xi, ACP Medical Student Member, is a first-year medical student at the OUWB School of Medicine, charter class of 2015, in Rochester, Mich., from which she which chronicles her journey through medical training from day 1 of medical school.
Ira S. Nash, MD, FACP, is the senior vice president and executive director of the North Shore-LIJ Medical Group, and a professor of Cardiology and Population Health at Hofstra North Shore-LIJ School of Medicine. He is Board Certified in Internal Medicine and Cardiovascular Diseases and was in the private practice of cardiology before joining the full-time faculty of Massachusetts General Hospital.
Zackary Berger, MD, ACP Member, is a primary care doctor and general internist in the Division of General Internal Medicine at Johns Hopkins. His research interests include doctor-patient communication, bioethics, and systematic reviews.
Controversies in Hospital
Run by three ACP Fellows, this blog ponders vexing issues in infection prevention and control, inside and outside the hospital. Daniel J Diekema, MD, FACP, practices infectious diseases, clinical microbiology, and hospital epidemiology in Iowa City, Iowa, splitting time between seeing patients with infectious diseases, diagnosing infections in the microbiology laboratory, and trying to prevent infections in the hospital. Michael B. Edmond, MD, FACP, is a hospital epidemiologist in Iowa City, IA, with a focus on understanding why infections occur in the hospital and ways to prevent these infections, and sees patients in the inpatient and outpatient settings. Eli N. Perencevich, MD, ACP Member, is an infectious disease physician and epidemiologist in Iowa City, Iowa, who studies methods to halt the spread of resistant bacteria in our hospitals (including novel ways to get everyone to wash their hands).
db's Medical Rants
Robert M. Centor, MD, FACP, contributes short essays contemplating medicine and the health care system.
Suneel Dhand, MD, ACP Member
Suneel Dhand, MD, ACP Member, is a practicing physician in Massachusetts. He has published numerous articles in clinical medicine, covering a wide range of specialty areas including; pulmonology, cardiology, endocrinology, hematology, and infectious disease. He has also authored chapters in the prestigious "5-Minute Clinical Consult" medical textbook. His other clinical interests include quality improvement, hospital safety, hospital utilization, and the use of technology in health care.
Juliet K. Mavromatis, MD, FACP, provides a conversation about health topics for patients and health professionals.
Dr. Mintz' Blog
Matthew Mintz, MD, FACP, has practiced internal medicine for more than a decade and is an Associate Professor of Medicine at an academic medical center on the East Coast. His time is split between teaching medical students and residents, and caring for patients.
Toni Brayer, MD, FACP, blogs about the rapid changes in science, medicine, health and healing in the 21st century.
Vineet Arora, MD, FACP, is Associate Program Director for the Internal Medicine Residency and Assistant Dean of Scholarship & Discovery at the Pritzker School of Medicine for the University of Chicago. Her education and research focus is on resident duty hours, patient handoffs, medical professionalism, and quality of hospital care. She is also an academic hospitalist.
John H. Schumann, MD, FACP, provides transparency on the workings of medical practice and the complexities of hospital care, illuminates the emotional and cognitive aspects of caregiving and decision-making from the perspective of an active primary care physician, and offers behind-the-scenes portraits of hospital sanctums and the people who inhabit them.
Ryan Madanick, MD, ACP Member, is a gastroenterologist at the University of North Carolina School of Medicine, and the Program Director for the GI & Hepatology Fellowship Program. He specializes in diseases of the esophagus, with a strong interest in the diagnosis and treatment of patients who have difficult-to-manage esophageal problems such as refractory GERD, heartburn, and chest pain.
Mike Aref, MD, PhD, FACP, is an academic hospitalist with an interest in basic and clinical science and education, with interests in noninvasive monitoring and diagnostic testing using novel bedside imaging modalities, diagnostic reasoning, medical informatics, new medical education modalities, pre-code/code management, palliative care, patient-physician communication, quality improvement, and quantitative biomedical imaging.
William Hersh, MD, FACP, Professor and Chair, Department of Medical Informatics & Clinical Epidemiology, Oregon Health & Science University, posts his thoughts on various topics related to biomedical and health informatics.
David Katz, MD
David L. Katz, MD, MPH, FACP, is an internationally renowned authority on nutrition, weight management, and the prevention of chronic disease, and an internationally recognized leader in integrative medicine and patient-centered care.
Richard Just, MD, ACP Member, has 36 years in clinical practice of hematology and medical oncology. His blog is a joint publication with Gregg Masters, MPH.
Kevin Pho, MD, ACP Member, offers one of the Web's definitive sites for influential health commentary.
Michael Kirsch, MD, FACP, addresses the joys and challenges of medical practice, including controversies in the doctor-patient relationship, medical ethics and measuring medical quality. When he's not writing, he's performing colonoscopies.
Elaine Schattner, MD, FACP, shares her ideas on education, ethics in medicine, health care news and culture. Her views on medicine are informed by her past experiences in caring for patients, as a researcher in cancer immunology, and as a patient who's had breast cancer.
Mired in MedEd
Alexander M. Djuricich, MD, FACP, is the Associate Dean for Continuing Medical Education (CME), and a Program Director in Medicine-Pediatrics at the Indiana University School of Medicine in Indianapolis, where he blogs about medical education.
Rob Lamberts, MD, ACP Member, a med-peds and general practice internist, returns with "volume 2" of his personal musings about medicine, life, armadillos and Sasquatch at More Musings (of a Distractible Kind).
David M. Sack, MD, FACP, practices general gastroenterology at a small community hospital in Connecticut. His blog is a series of musings on medicine, medical care, the health care system and medical ethics, in no particular order.
Reflections of a Grady
Kimberly Manning, MD, FACP, reflects on the personal side of being a doctor in a community hospital in Atlanta.
The Blog of Paul Sufka
Paul Sufka, MD, ACP Member, is a board certified rheumatologist in St. Paul, Minn. He was a chief resident in internal medicine with the University of Minnesota and then completed his fellowship training in rheumatology in June 2011 at the University of Minnesota Department of Rheumatology. His interests include the use of technology in medicine.
Technology in (Medical)
Neil Mehta, MBBS, MS, FACP, is interested in use of technology in education, social media and networking, practice management and evidence-based medicine tools, personal information and knowledge management.
Peter A. Lipson,
Peter A. Lipson, MD, ACP Member, is a practicing internist and teaching physician in Southeast Michigan. The blog, which has been around in various forms since 2007, offers musings on the intersection of science, medicine, and culture.
Why is American Health Care So Expensive?
Janice Boughton, MD, FACP, practiced internal medicine for 20 years before adopting a career in hospital and primary care medicine as a locum tenens physician. She lives in Idaho when not traveling.
World's Best Site
Daniel Ginsberg, MD, FACP, is an internal medicine physician who has avidly applied computers to medicine since 1986, when he first wrote medically oriented computer programs. He is in practice in Tacoma, Washington.
Other blogs of note:
American Journal of
Also known as the Green Journal, the American Journal of Medicine publishes original clinical articles of interest to physicians in internal medicine and its subspecialities, both in academia and community-based practice.
A collaborative medical blog started by Neil Shapiro, MD, ACP Member, associate program director at New York University Medical Center's internal medicine residency program. Faculty, residents and students contribute case studies, mystery quizzes, news, commentary and more.
Michael Benjamin, MD, ACP member, doesn't accept industry money so he can create an independent, clinician-reviewed space on the Internet for physicians to report and comment on the medical news of the day.
The Public Library of Science's open access materials include a blog.
One of the most popular anonymous blogs written by an emergency room physician.